Curtousy of TedJ..bang on BigEgo commented
Post# of 22465
(Total Views: 360)
Posted On: 02/04/2021 1:52:54 PM
Curtousy of TedJ..bang on
BigEgo commented
"The QD's might just be colloidal gold particles which are spelled out in the respective EUA's."
Ted's reply
I think you are missing the point of the slides. The majority of the common antibody and antigen LFDs (like Biotimes) do use colloidal gold/silver nanoparticles to bind to antibodies/antigens. And these are commodities and these tests are qualitative tests (antibodies present? yes/no).
But the slides present a different test approach that use molecular quantum dots. The point is this type of testing is more sophisticated and quantitative (how much of the different antibodies are present). These tests need the point of care laboratory grade reader to provide the results. These readers have existed prior to covid.
My guess is that the reader is not a new ground up development by QMC, Innova, Pasaca or Malan, but provided by someone else.
I would be happy if Innova is going to manufacture the lateral flow cassettes using quantum dots supplied by QMC. If Pasaca has another portfolio company that already is involved in POC readers, then they maybe supplied "in-house", but it not a necessity. And the QMCHID app and block chain ledger would tie things together with reporting.
So the "development of a functioning product integrating the QMC™ HealthID IP and Innova Medical Group, Inc.’s products" maybe the integration is QMC's ledger IP with a third party reader system.
"
BigEgo commented
"The QD's might just be colloidal gold particles which are spelled out in the respective EUA's."
Ted's reply
I think you are missing the point of the slides. The majority of the common antibody and antigen LFDs (like Biotimes) do use colloidal gold/silver nanoparticles to bind to antibodies/antigens. And these are commodities and these tests are qualitative tests (antibodies present? yes/no).
But the slides present a different test approach that use molecular quantum dots. The point is this type of testing is more sophisticated and quantitative (how much of the different antibodies are present). These tests need the point of care laboratory grade reader to provide the results. These readers have existed prior to covid.
My guess is that the reader is not a new ground up development by QMC, Innova, Pasaca or Malan, but provided by someone else.
I would be happy if Innova is going to manufacture the lateral flow cassettes using quantum dots supplied by QMC. If Pasaca has another portfolio company that already is involved in POC readers, then they maybe supplied "in-house", but it not a necessity. And the QMCHID app and block chain ledger would tie things together with reporting.
So the "development of a functioning product integrating the QMC™ HealthID IP and Innova Medical Group, Inc.’s products" maybe the integration is QMC's ledger IP with a third party reader system.
"
(0)
(0)